Incorporated in Massachusetts in 1989, Vertex Pharmaceuticals Incorporated is a global biotechnology company dedicated to scientific innovation to create transformative medicines for individuals with serious diseases, especially in the specialty market. The company has developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain. The company continues to innovate and advance next-generation clinical and research projects across a variety of serious diseases, including IgA nephropathy and type 1 diabetes. 

Expected P&L on Expiry

Key Stats

Pricing Model

About VRTX20260402C270